Gian Luca Grazi Selected Research

Lysosomal-Associated Membrane Protein 1

4/2022

Impaired degradation of YAP1 and IL6ST by chaperone-mediated autophagy promotes proliferation and migration of normal and hepatocellular carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gian Luca Grazi Research Topics

Disease

38	Neoplasms (Cancer) 04/2022 - 02/2002
31	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 03/2002
19	Fibrosis (Cirrhosis) 01/2022 - 03/2002
11	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2002
9	Liver Failure 06/2022 - 06/2006
9	Hepatitis C 04/2015 - 11/2004
9	End Stage Liver Disease 12/2009 - 06/2006
6	Thrombosis (Thrombus) 01/2022 - 04/2003
6	Liver Diseases (Liver Disease) 01/2022 - 08/2002
6	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 02/2002
6	Infections 02/2016 - 03/2009
5	Cholangiocarcinoma 01/2022 - 07/2010
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 01/2016
4	Adenocarcinoma 01/2021 - 01/2016
3	Hepatitis 01/2022 - 11/2003
3	Portal Hypertension 11/2020 - 12/2009
3	Inflammation (Inflammations) 01/2019 - 06/2011
2	Overweight 01/2022 - 10/2017
2	Ascites 01/2022 - 10/2020
2	Obesity 01/2022 - 01/2019
2	Fatty Liver 01/2022 - 10/2017
2	Rectal Neoplasms (Rectal Cancer) 12/2019 - 01/2018
2	Chronic Hepatitis C 02/2016 - 11/2014
2	Virus Diseases (Viral Diseases) 02/2016 - 08/2002
2	Ischemia 07/2009 - 09/2003
2	Hemorrhage 02/2004 - 09/2003
1	Liver Neoplasms (Liver Cancer) 04/2022
1	Starvation 04/2022
1	Disease Progression 01/2022
1	Choledocholithiasis 01/2022
1	Sclerosing Cholangitis 01/2022
1	Genetic Risk Score 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020
1	Surgical Wound Infection 10/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019

Drug/Important Bio-Agent (IBA)

7	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022 - 03/2004
5	Proteins (Proteins, Gene)FDA Link 04/2022 - 11/2005
5	Antiviral Agents (Antivirals)IBA 04/2015 - 11/2003
4	MicroRNAs (MicroRNA)IBA 01/2019 - 07/2007
4	InterferonsIBA 02/2016 - 09/2004
4	Tacrolimus (Prograf)FDA LinkGeneric 01/2015 - 06/2004
3	AntibodiesIBA 01/2016 - 07/2009
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2015 - 11/2004
3	Calcineurin InhibitorsIBA 01/2015 - 11/2008
2	CytokinesIBA 04/2022 - 12/2006
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2002
2	6-propylchromone-2-carboxylic acid (PCCA)IBA 01/2022 - 01/2021
2	Protein Isoforms (Isoforms)IBA 11/2020 - 01/2016
2	EnzymesIBA 01/2019 - 08/2002
2	Biological ProductsIBA 01/2019 - 01/2010
2	Ribavirin (Virazole)FDA LinkGeneric 01/2015 - 09/2004
2	BilirubinIBA 10/2012 - 08/2002
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 08/2012 - 11/2005
2	Fetal Proteins (Fetoprotein)IBA 06/2011 - 09/2004
2	SodiumIBA 08/2010 - 01/2009
2	Cyclin G1IBA 07/2009 - 07/2007
2	Azathioprine (Imuran)FDA LinkGeneric 07/2009 - 11/2004
2	SteroidsIBA 12/2007 - 11/2004
2	Messenger RNA (mRNA)IBA 09/2007 - 11/2005
1	pyridineIBA 04/2022
1	Verteporfin (Visudyne)FDA Link 04/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2022
1	TubulinIBA 04/2022
1	Interleukin-6 (Interleukin 6)IBA 04/2022
1	Mitogen-Activated Protein Kinase 8IBA 04/2022
1	Voltage-Dependent Anion Channel 1IBA 04/2022
1	Lysosomal Membrane ProteinsIBA 04/2022
1	Lysosomal-Associated Membrane Protein 1IBA 04/2022
1	Janus KinasesIBA 04/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	Bacteroides fragilis toxinIBA 01/2021
1	Bacterial ToxinsIBA 01/2021
1	LigandsIBA 11/2020
1	Lipase (Acid Lipase)FDA Link 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Conditioned Culture MediaIBA 01/2018
1	CateninsIBA 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2017
1	MucinsIBA 01/2017
1	Cre recombinaseIBA 09/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2016

Therapy/Procedure

33	Liver Transplantation 06/2022 - 03/2002
17	Hepatectomy 06/2022 - 05/2003
12	Therapeutics 01/2022 - 11/2004
11	Transplantation 01/2021 - 09/2003
4	Contraindications 01/2021 - 10/2002
4	Drug Therapy (Chemotherapy) 12/2019 - 07/2004
4	Pancreatectomy 01/2019 - 01/2016
3	Blood Transfusion (Blood Transfusions) 11/2020 - 10/2017
2	Length of Stay 10/2020 - 12/2009
2	Neoadjuvant Therapy 12/2019 - 01/2018
2	Combined Modality Therapy 10/2012 - 07/2010
2	Perioperative Care 06/2011 - 12/2009
2	Lymph Node Excision (Lymph Node Dissection) 08/2010 - 02/2004
1	Minimally Invasive Surgical Procedures 10/2020
1	Operative Time 10/2020
1	Re-Irradiation 12/2019
1	Ligation 06/2016